KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Depreciation & Amortization (CF) (2016 - 2025)

Amgen (AMGN) has 17 years of Depreciation & Amortization (CF) data on record, last reported at $1.1 billion in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 18.97% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $5.2 billion, down 7.6%, while the annual FY2025 figure was $5.2 billion, 7.6% down from the prior year.
  • Depreciation & Amortization (CF) reached $1.1 billion in Q4 2025 per AMGN's latest filing, down from $1.3 billion in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.4 billion in Q2 2024 and bottomed at $828.0 million in Q2 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $1.1 billion, with a median of $905.5 million recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 56.25% in 2024, then fell 18.97% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $852.0 million in 2021, then rose by 6.92% to $911.0 million in 2022, then skyrocketed by 51.48% to $1.4 billion in 2023, then rose by 1.23% to $1.4 billion in 2024, then decreased by 18.97% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $1.1 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.3 billion in Q2 2025.